Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 3 studies | 25% ± 4% | |
glutamatergic neuron | 3 studies | 46% ± 19% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 34% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 2402.03 | 226 / 226 | 100% | 40.29 | 406 / 406 |
uterus | 100% | 1760.92 | 170 / 170 | 100% | 56.75 | 459 / 459 |
esophagus | 100% | 3497.56 | 1443 / 1445 | 100% | 71.24 | 183 / 183 |
skin | 100% | 4003.78 | 1809 / 1809 | 100% | 65.06 | 471 / 472 |
pancreas | 100% | 1491.80 | 327 / 328 | 100% | 48.92 | 178 / 178 |
intestine | 100% | 2561.51 | 966 / 966 | 100% | 65.11 | 525 / 527 |
brain | 99% | 2416.54 | 2621 / 2642 | 100% | 48.64 | 705 / 705 |
prostate | 100% | 1588.00 | 244 / 245 | 100% | 60.17 | 500 / 502 |
stomach | 100% | 1627.89 | 358 / 359 | 99% | 60.69 | 284 / 286 |
thymus | 100% | 2065.74 | 651 / 653 | 99% | 45.50 | 600 / 605 |
bladder | 100% | 1981.90 | 21 / 21 | 99% | 71.32 | 498 / 504 |
breast | 100% | 1544.57 | 457 / 459 | 99% | 58.23 | 1106 / 1118 |
kidney | 100% | 2903.98 | 89 / 89 | 98% | 32.80 | 886 / 901 |
adrenal gland | 100% | 1704.94 | 258 / 258 | 98% | 38.89 | 225 / 230 |
lung | 97% | 1559.51 | 559 / 578 | 99% | 45.67 | 1145 / 1155 |
ovary | 97% | 990.36 | 175 / 180 | 98% | 31.03 | 421 / 430 |
eye | 0% | 0 | 0 / 0 | 100% | 55.14 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 33.09 | 29 / 29 |
spleen | 100% | 1338.25 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 60.90 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 103.08 | 1 / 1 |
blood vessel | 99% | 1537.79 | 1324 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 1417.08 | 1193 / 1204 | 0% | 0 | 0 / 0 |
heart | 95% | 1342.48 | 816 / 861 | 0% | 0 | 0 / 0 |
muscle | 93% | 1224.96 | 749 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 60% | 485.47 | 562 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007584 | Biological process | response to nutrient |
GO_0015909 | Biological process | long-chain fatty acid transport |
GO_0090630 | Biological process | activation of GTPase activity |
GO_0150104 | Biological process | transport across blood-brain barrier |
GO_0042760 | Biological process | very long-chain fatty acid catabolic process |
GO_0046627 | Biological process | negative regulation of insulin receptor signaling pathway |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0051649 | Biological process | establishment of localization in cell |
GO_0044381 | Biological process | glucose import in response to insulin stimulus |
GO_0015908 | Biological process | fatty acid transport |
GO_0044539 | Biological process | long-chain fatty acid import into cell |
GO_0001676 | Biological process | long-chain fatty acid metabolic process |
GO_0001579 | Biological process | medium-chain fatty acid transport |
GO_0043588 | Biological process | skin development |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_1990379 | Biological process | lipid transport across blood-brain barrier |
GO_0031526 | Cellular component | brush border membrane |
GO_0005902 | Cellular component | microvillus |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005324 | Molecular function | long-chain fatty acid transmembrane transporter activity |
GO_0015245 | Molecular function | fatty acid transmembrane transporter activity |
GO_0031957 | Molecular function | very long-chain fatty acid-CoA ligase activity |
GO_0004467 | Molecular function | long-chain fatty acid-CoA ligase activity |
GO_0090433 | Molecular function | palmitoyl-CoA ligase activity |
GO_0090434 | Molecular function | oleoyl-CoA ligase activity |
GO_0000166 | Molecular function | nucleotide binding |
GO_0047676 | Molecular function | arachidonate-CoA ligase activity |
GO_1901480 | Molecular function | oleate transmembrane transporter activity |
Gene name | SLC27A4 |
Protein name | Long-chain fatty acid transport protein 4 (FATP-4) (Fatty acid transport protein 4) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 4) (Very long-chain acyl-CoA synthetase 4) (ACSVL4) (EC 6.2.1.-) |
Synonyms | FATP4 ACSVL4 |
Description | FUNCTION: Mediates the levels of long-chain fatty acids (LCFA) in the cell by facilitating their transport across cell membranes . Appears to be the principal fatty acid transporter in small intestinal enterocytes . Also functions as an acyl-CoA ligase catalyzing the ATP-dependent formation of fatty acyl-CoA using LCFA and very-long-chain fatty acids (VLCFA) as substrates, which prevents fatty acid efflux from cells and might drive more fatty acid uptake . Plays a role in the formation of the epidermal barrier. Required for fat absorption in early embryogenesis (By similarity). Probably involved in fatty acid transport across the blood barrier . Indirectly inhibits RPE65 via substrate competition and via production of VLCFA derivatives like lignoceroyl-CoA. Prevents light-induced degeneration of rods and cones (By similarity). . |
Accessions | ENST00000300456.5 [Q6P1M0-1] Q6P1M0 ENST00000372870.5 [Q6P1M0-2] |